-
Featured Authors
-
Archives
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Author Archive: Tracy Cooley
Tracy serves as the Director of Events Communications and handles all communications for BIO’s events and emerging company policy issues. She loves blogging and podcasting on all things biotech and believes in the great potential of the industry, looking for every opportunity to spread the message far and wide. Nearly everyone in her family is a golfer, and as such, she has what many people have called a “natural” swing. Sometimes she even hits the ball. Tracy just finished her ninth marathon, and has nearly mastered the skill of one-foot-in-front-of-the-other (usually, sometimes the laces get in the way). The joy of her life is her five-year-old daughter Josephine.
Latest Posts
4 Benefits of Plant-Made Pharmaceuticals
For centuries, plants have served as a natural source of treatments and therapies. New advances in biotechnology make it possible to turn plants into “factories” that produce therapeutic proteins for use in the manufacture of biologics. The potential of plant-made pharmaceuticals to combat life-threatening diseases has been in the news recently as they may be helpful in treating Ebola. Developing therapeutic proteins in plants can be a safer, more efficient and cost-effective method of protein Read More >
Promising vaccine companies set to take the stage at BIO Investor Forum
It is no secret that vaccines are a hot space in biotech right now, and the 13th Annual BIO Investor Forum will feature several companies working on promising vaccine R&D. The event, scheduled for October 7-8 in San Francisco, Calif., will feature 120 late-stage private and emerging public company presentations. Attendees at the BIO Investor Forum will hear from Immunovaccine, a clinical-stage vaccine development company focused on product candidates for cancer therapy, infectious disease and Read More >
AP: Groups Claim Insurance Discrimination
In this August 18 article, Ricardo Alonso-Zaldivar highlights assertions by patient groups that new insurance barriers are discriminatory against sick people, particularly patients with chronic conditions. More than 300 patient advocacy groups – including the AIDS Institute, the American Lung Association, Easter Seals, the Epilepsy Foundation, the Leukemia & Lymphoma Society, the National Alliance on Mental Illness, the National Kidney Foundation and United Cerebral Palsy – recently wrote to Health and Human Services Secretary Sylvia Read More >
Health
Leave a comment
Email This Post
Tags: AIDS Institute, American Lung Association, Easter Seals, Epilepsy Foundation, health, Health and Human Services Secretary, Insurance Discrimination, Leukemia & Lymphoma Society, National Alliance on Mental Illness, National Kidney Foundation, Ricardo Alonso-Zaldivar, Sylvia Mathews Burwell, United Cerebral Palsy
Tags: AIDS Institute, American Lung Association, Easter Seals, Epilepsy Foundation, health, Health and Human Services Secretary, Insurance Discrimination, Leukemia & Lymphoma Society, National Alliance on Mental Illness, National Kidney Foundation, Ricardo Alonso-Zaldivar, Sylvia Mathews Burwell, United Cerebral Palsy
Docs to FDA: Biosimilars should have different names than branded drugs
Yesterday, Fierce Biotech highlighted a letter written by more than 10 medical associations and 20 individual specialists to FDA Commissioner Margaret Hamburg saying that biosimilars “must have distinguishable nonproprietary names. The FDA drafted a set of rules for biosimilars in 2012, sparking a debate on whether those drugs should carry the same generic names as the originator products. Now, some doctors are weighing in on the issue, urging the FDA to require biosimilars to have distinguishable names. The physicians argued that using different Read More >
New study shows hepatitis C burden may ease in future
Anew study published in the Annals of Internal Medicine projects that the prevalence of hepatitis C will shrink in the coming decades thanks to new medicines and increased screening regimens. Currently, approximately one in 100 people are infected with the virus, and researchers expect that number to drop to about one in 1,500 people by 2036 if patients have timely and affordable treatment. “We were pleasantly surprised that in the next 22 years we could Read More >
